v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ (154,823) $ (872,498)
Adjustments to reconcile net income (loss) to net cash provided by (used by) operating activities:    
Depreciation and amortization 14,084 10,602
Bad debt expense 35,779 16,439
Amortization of discount on investment in account receivable (57,755) (68,784)
Gain on sale of investment in Brighter Day Health (53,058) 0
Increase in accrued of investment interest income (1,588) (1,832)
Gain on investment in securities, at fair value (269,548) 163,445
Gain on long-term investments (33,249) 0
Decrease (increase) in operating assets    
Cash in attorney trust accounts 314,536 (300,000)
Finance leases receivable 58,281 0
Accounts receivable - trade (62,311) (85,002)
Prepaid expenses and other current assets 460 13,611
Employee advances (3,229) (9,608)
Increase (decrease) in operating liabilities    
Accounts payable (5,250) 6,940
Accrued expenses 22,168 (2,573)
Deferred revenue 97,920 0
Accrued salary, retirement and benefits - related party 49,539 101,586
Net cash provided by (used by) operating activities (48,044) (1,027,674)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from receivable - Bhang Corporation 1,987,099 0
Purchase of investment securities (236,272) (1,071,901)
Proceeds from investment securities sold 0 754,643
Cash advanced on convertible notes receivable 0 (100,000)
Proceeds from convertible notes receivable 4,140 5,194
Cash advanced on notes receivable (179,000) (800,000)
Proceeds from notes receivable 24,750 11,724
Deposits on equipment to be leased (797,563) 0
Addition to finance receivables (593,958) 0
Purchases of property and equipment (17,541) (7,909)
Proceeds from sale of investment in Brighter Day Health 109,000 0
Purchase of long-term investment (5,669) 0
Proceeds from investment in receivable 117,000 0
Net cash provided by (used by) investing activities 411,986 (1,208,249)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Warrants converted to common stock, net of costs 401,055 2,203,105
Issuance of Series Q preferred shares, net of cost 109,985 0
Payments on long-term debt (24,023) (27,291)
Non-controlling interest distribution (2,745) (13,437)
Net cash provided by (used by) financing activities 484,272 2,162,377
Net change in cash 848,214 (73,546)
Beginning cash 834,190 1,311,338
Ending cash 1,682,404 1,237,792
SUPPLEMENTARY INFORMATION:    
Cash paid for interest 11,650 3,431
Cash paid for income taxes 18,870 11,770
NON-CASH INVESTING AND FINANCING TRANSACTIONS:    
Shareholder assumption of warrant liability resulting in increased liability to shareholder 15,276 (80,054)
Contractual interest in legal recovery purchased through issuance of 288,890 shares of restricted common stock in a private offering 0 600,002
Conversion of Electrum convertible notes receivable to equity interest in Electrum 86,256 107,772
Bhang Corporation receivable cancelled by return of Mentor common Stock $ 228,150 $ 0

Source